Oncology

sponsor

Topics in Oncology

Alternative Therapies

Anemia/Polycythemia

Basic Science/Genetics

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

Gynecologic Oncology

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain Management/
Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Soft Tissue/Sarcoma

Transfusion Medicine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Top Ten Searches

brca1

prostate-specific antigen

sclc

fobt

egd

bmi

dysplasia

hematologic

ovarian

hcc

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus
Journal of Thrombosis and Haemostasis, 07/01/09

Pauzner R et al. - A large proportion of patients with APS and/or SLE give false-positive HIT antigen test results that are presumably related to autoantibodies against PF4, which can be distinguished from true HIT antibodies by EIA for PF4–heparin complexes tested with heparin excess, and by functional assays.

<< Previous
Ewing sarcoma demonstrates racial disparities in...

Next >>
Calcium signaling in platelets

Today in Coagulation/Bleeding Dz...keeping you current

Management of the antiphospholipid syndrome: new approaches
International Journal of Clinical Rheumatology, 10/19/09

Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09

Sickle cell disease and stroke
Blood, 10/13/09

See All of Coagulation/Bleeding Dz

Today in Diagnostics/Radiology...keeping you current

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09

See All of Diagnostics/Radiology

Sponsor

Article Search

Sponsor

Sponsor

Send this Summary to a Colleague